71 related articles for article (PubMed ID: 27839686)
1. Discovery of a potent and selective ROMK inhibitor with improved pharmacokinetic properties based on an octahydropyrazino[2,1-c][1,4]oxazine scaffold.
Zhu Y; de Jesus RK; Tang H; Walsh SP; Jiang J; Gu X; Teumelsan N; Shahripour A; Pio B; Ding FX; Ha S; Priest BT; Swensen AM; Alonso-Galicia M; Felix JP; Brochu RM; Bailey T; Thomas-Fowlkes B; Zhou X; Pai LY; Hampton C; Hernandez M; Owens K; Ehrhart J; Roy S; Kaczorowski GJ; Yang L; Parmee ER; Sullivan K; Garcia ML; Pasternak A
Bioorg Med Chem Lett; 2016 Dec; 26(23):5695-5702. PubMed ID: 27839686
[TBL] [Abstract][Full Text] [Related]
2. Discovery of a novel sub-class of ROMK channel inhibitors typified by 5-(2-(4-(2-(4-(1H-Tetrazol-1-yl)phenyl)acetyl)piperazin-1-yl)ethyl)isobenzofuran-1(3H)-one.
Tang H; de Jesus RK; Walsh SP; Zhu Y; Yan Y; Priest BT; Swensen AM; Alonso-Galicia M; Felix JP; Brochu RM; Bailey T; Thomas-Fowlkes B; Zhou X; Pai LY; Hampton C; Hernandez M; Owens K; Roy S; Kaczorowski GJ; Yang L; Garcia ML; Pasternak A
Bioorg Med Chem Lett; 2013 Nov; 23(21):5829-32. PubMed ID: 24075732
[TBL] [Abstract][Full Text] [Related]
3. Improvement of hERG-ROMK index of spirocyclic ROMK inhibitors through scaffold optimization and incorporation of novel pharmacophores.
Dong S; VanGelder K; Shi ZC; Yu Y; Wu Z; Ferguson R; Guo ZZ; Tang H; Frie J; Fu Q; Gu X; Priest BT; Thomas-Fowlkes B; Weinglass A; Margulis M; Liu J; Pai LY; Hampton C; Haimbach RE; Owens K; Tong V; Xu S; Hu M; Zingaro GJ; Morissette P; Ehrhart J; Roy S; Sullivan K; Pasternak A
Bioorg Med Chem Lett; 2017 Jun; 27(11):2559-2566. PubMed ID: 28431879
[TBL] [Abstract][Full Text] [Related]
4. Discovery of BMS-986308: A Renal Outer Medullary Potassium Channel Inhibitor for the Treatment of Heart Failure.
Richter JM; Gunaga P; Yadav N; Bora RO; Bhide R; Rajugowda N; Govindrajulu K; Godesi S; Akuthota N; Rao P; Sivaraman A; Panda M; Kaspady M; Gupta A; Mathur A; Levesque PC; Gulia J; Dokania M; Ramarao M; Kole P; Chacko S; Lentz KA; Sivaprasad Lvj S; Thatipamula RP; Sridhar S; Kamble S; Govindrajan A; Soleman SI; Gordon DA; Wexler RR; Priestley ES
J Med Chem; 2024 Jun; 67(11):9731-9744. PubMed ID: 38807539
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologic inhibition of the renal outer medullary potassium channel causes diuresis and natriuresis in the absence of kaliuresis.
Garcia ML; Priest BT; Alonso-Galicia M; Zhou X; Felix JP; Brochu RM; Bailey T; Thomas-Fowlkes B; Liu J; Swensen A; Pai LY; Xiao J; Hernandez M; Hoagland K; Owens K; Tang H; de Jesus RK; Roy S; Kaczorowski GJ; Pasternak A
J Pharmacol Exp Ther; 2014 Jan; 348(1):153-64. PubMed ID: 24142912
[TBL] [Abstract][Full Text] [Related]
6. The design and synthesis of novel spirocyclic heterocyclic sulfone ROMK inhibitors as diuretics.
Chobanian HR; Guo Y; Pio B; Tang H; Teumelsan N; Clements M; Frie J; Ferguson R; Guo Z; Thomas-Fowlkes BS; Felix JP; Liu J; Kohler M; Priest B; Hampton C; Pai LY; Corona A; Metzger J; Tong V; Joshi EM; Xu L; Owens K; Maloney K; Sullivan K; Pasternak A
Bioorg Med Chem Lett; 2017 Feb; 27(4):1109-1114. PubMed ID: 28111141
[TBL] [Abstract][Full Text] [Related]
7. Differentiation of ROMK potency from hERG potency in the phenacetyl piperazine series through heterocycle incorporation.
Walsh SP; Shahripour A; Tang H; de Jesus RK; Teumelsan N; Zhu Y; Frie J; Priest BT; Swensen AM; Alonso-Galicia M; Felix JP; Brochu RM; Bailey T; Thomas-Fowlkes B; Zhou X; Pai LY; Hampton C; Hernandez M; Owens K; Ehrhart J; Roy S; Kaczorowski GJ; Yang L; Garcia ML; Pasternak A
Bioorg Med Chem Lett; 2016 May; 26(9):2339-43. PubMed ID: 27017115
[TBL] [Abstract][Full Text] [Related]
8. The Renal Outer Medullary Potassium Channel Inhibitor, MK-7145, Lowers Blood Pressure, and Manifests Features of Bartter's Syndrome Type II Phenotype.
Hampton C; Zhou X; Priest BT; Pai LY; Felix JP; Thomas-Fowlkes B; Liu J; Kohler M; Xiao J; Corona A; Price O; Gill C; Shah K; Rasa C; Tong V; Owens K; Ormes J; Tang H; Roy S; Sullivan KA; Metzger JM; Alonso-Galicia M; Kaczorowski GJ; Pasternak A; Garcia ML
J Pharmacol Exp Ther; 2016 Oct; 359(1):194-206. PubMed ID: 27432892
[TBL] [Abstract][Full Text] [Related]
9. Discovery of MK-8153, a Potent and Selective ROMK Inhibitor and Novel Diuretic/Natriuretic.
Jiang J; Ding FX; Zhou X; Bateman TJ; Dong S; Gu X; Keh deJesus R; Pio B; Tang H; Chobanian HR; Levorse D; Hu M; Thomas-Fowlkes B; Margulis M; Koehler M; Weinglass A; Gibson J; Houle K; Yudkovitz J; Hampton C; Pai LY; Samuel K; Cutarelli T; Sullivan K; Parmee ER; Davies I; Pasternak A
J Med Chem; 2021 Jun; 64(11):7691-7701. PubMed ID: 34038119
[TBL] [Abstract][Full Text] [Related]
10. Discovery of MK-7145, an Oral Small Molecule ROMK Inhibitor for the Treatment of Hypertension and Heart Failure.
Tang H; Zhu Y; Teumelsan N; Walsh SP; Shahripour A; Priest BT; Swensen AM; Felix JP; Brochu RM; Bailey T; Thomas-Fowlkes B; Pai LY; Hampton C; Corona A; Hernandez M; Metzger J; Forrest M; Zhou X; Owens K; Tong V; Parmee E; Roy S; Kaczorowski GJ; Yang L; Alonso-Galicia M; Garcia ML; Pasternak A
ACS Med Chem Lett; 2016 Jul; 7(7):697-701. PubMed ID: 27437080
[TBL] [Abstract][Full Text] [Related]
11. Discovery of 6-phenylpyrimido[4,5-b][1,4]oxazines as potent and selective acyl CoA:diacylglycerol acyltransferase 1 (DGAT1) inhibitors with in vivo efficacy in rodents.
Fox BM; Sugimoto K; Iio K; Yoshida A; Zhang JK; Li K; Hao X; Labelle M; Smith ML; Rubenstein SM; Ye G; McMinn D; Jackson S; Choi R; Shan B; Ma J; Miao S; Matsui T; Ogawa N; Suzuki M; Kobayashi A; Ozeki H; Okuma C; Ishii Y; Tomimoto D; Furakawa N; Tanaka M; Matsushita M; Takahashi M; Inaba T; Sagawa S; Kayser F
J Med Chem; 2014 Apr; 57(8):3464-83. PubMed ID: 24670009
[TBL] [Abstract][Full Text] [Related]
12. Discovery of Selective Small Molecule ROMK Inhibitors as Potential New Mechanism Diuretics.
Tang H; Walsh SP; Yan Y; de Jesus RK; Shahripour A; Teumelsan N; Zhu Y; Ha S; Owens KA; Thomas-Fowlkes BS; Felix JP; Liu J; Kohler M; Priest BT; Bailey T; Brochu R; Alonso-Galicia M; Kaczorowski GJ; Roy S; Yang L; Mills SG; Garcia ML; Pasternak A
ACS Med Chem Lett; 2012 May; 3(5):367-72. PubMed ID: 24900480
[TBL] [Abstract][Full Text] [Related]
13. Discovery of a Potent and Selective ROMK Inhibitor with Pharmacokinetic Properties Suitable for Preclinical Evaluation.
Walsh SP; Shahripour A; Tang H; Teumelsan N; Frie J; Zhu Y; Priest BT; Swensen AM; Liu J; Margulis M; Visconti R; Weinglass A; Felix JP; Brochu RM; Bailey T; Thomas-Fowlkes B; Alonso-Galicia M; Zhou X; Pai LY; Corona A; Hampton C; Hernandez M; Bentley R; Chen J; Shah K; Metzger J; Forrest M; Owens K; Tong V; Ha S; Roy S; Kaczorowski GJ; Yang L; Parmee E; Garcia ML; Sullivan K; Pasternak A
ACS Med Chem Lett; 2015 Jul; 6(7):747-52. PubMed ID: 26191360
[TBL] [Abstract][Full Text] [Related]
14. Targeting the inward-rectifier potassium channel ROMK in cardiovascular disease.
Garcia ML; Kaczorowski GJ
Curr Opin Pharmacol; 2014 Apr; 15():1-6. PubMed ID: 24721647
[TBL] [Abstract][Full Text] [Related]
15. Discovery of Small Molecule Renal Outer Medullary Potassium (ROMK) Channel Inhibitors: A Brief History of Medicinal Chemistry Approaches To Develop Novel Diuretic Therapeutics.
Aretz CD; Vadukoot AK; Hopkins CR
J Med Chem; 2019 Oct; 62(19):8682-8694. PubMed ID: 31034224
[TBL] [Abstract][Full Text] [Related]
16. Discovery of Potent and Centrally Active 6-Substituted 5-Fluoro-1,3-dihydro-oxazine β-Secretase (BACE1) Inhibitors via Active Conformation Stabilization.
Nakahara K; Fuchino K; Komano K; Asada N; Tadano G; Hasegawa T; Yamamoto T; Sako Y; Ogawa M; Unemura C; Hosono M; Ito H; Sakaguchi G; Ando S; Ohnishi S; Kido Y; Fukushima T; Dhuyvetter D; Borghys H; Gijsen HJM; Yamano Y; Iso Y; Kusakabe KI
J Med Chem; 2018 Jul; 61(13):5525-5546. PubMed ID: 29775538
[TBL] [Abstract][Full Text] [Related]
17. Development of a selective small-molecule inhibitor of Kir1.1, the renal outer medullary potassium channel.
Bhave G; Chauder BA; Liu W; Dawson ES; Kadakia R; Nguyen TT; Lewis LM; Meiler J; Weaver CD; Satlin LM; Lindsley CW; Denton JS
Mol Pharmacol; 2011 Jan; 79(1):42-50. PubMed ID: 20926757
[TBL] [Abstract][Full Text] [Related]
18. Inhibitors of the renal outer medullary potassium channel: a patent review.
Martelli A; Testai L; Breschi MC; Calderone V
Expert Opin Ther Pat; 2015; 25(9):1035-51. PubMed ID: 26004420
[TBL] [Abstract][Full Text] [Related]
19. The inwardly rectifying potassium channel Kir1.1: development of functional assays to identify and characterize channel inhibitors.
Felix JP; Priest BT; Solly K; Bailey T; Brochu RM; Liu CJ; Kohler MG; Kiss L; Alonso-Galicia M; Tang H; Pasternak A; Kaczorowski GJ; Garcia ML
Assay Drug Dev Technol; 2012 Oct; 10(5):417-31. PubMed ID: 22881347
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
